The days right after a company goes public are some of the most volatile in its entire trading history. Supply and demand haven't found their footing yet, and a stock can swing wildly on relatively thin volume. To keep that first stretch from turning into a disorderly mess, underwriters (the investment banks running the IPO) lean on a set of tools built around the greenshoe option (a legal clause letting banks sell extra shares to help stabilize the stock) and SEC Regulation M, specifically Rule 104.
For institutional investors, understanding how these tools work together isn't just background knowledge. It's the difference between reading a stock's early price action correctly and mistaking artificial support for genuine investor demand, a distinction covered from the pricing side in our pillar reference on IPO market microstructure.
What Underwriters Can and Cannot Do Under Rule 104
Underwriters don't have free rein to prop up a stock however they like. SEC Rule 104 of Regulation M makes it unlawful to stabilize a security's price except under a specific, narrow set of conditions.
Rule | What It Means | Real-World Impact |
Permitted purpose | Stabilizing bids can only slow or stop a falling price | It's strictly a downside tool, never a way to push the price higher |
Price limit | A stabilizing bid can't exceed the original offer price | Prevents underwriters from artificially inflating the stock above what buyers agreed to pay |
Disclosure | The intent to stabilize must be stated in the prospectus | Investors know upfront that this kind of support could happen |
Notification | Underwriters must notify the market when a stabilizing bid starts or is withdrawn | Keeps the process transparent to regulators and other market participants |
A related but separate rule worth knowing: Rule 105 of Regulation M restricts short selling a stock shortly before a public offering and then covering that short with shares bought in the offering itself, closing off a way traders could otherwise profit from artificially depressing the price right before it prices.
How the Greenshoe Option Actually Works
The greenshoe (formally an overallotment option) gives underwriters the right, not the obligation, to buy up to 15% more shares from the company at the original offer price. It's effectively self-funding, and it plays out in one of two ways depending on how the stock trades.
If the price falls below the offer price: underwriters use proceeds from having initially oversold shares (a synthetic short position, meaning they've sold more shares than they actually hold) to buy shares back on the open market. That buying activity helps absorb selling pressure and establishes a rough price floor.
If the price rises above the offer price: underwriters can't cover their short position cheaply on the open market anymore, so instead they exercise the greenshoe and buy the extra shares directly from the company at the original offer price. This expands the company's total proceeds. SpaceX's June 2026 IPO is the clearest recent example of this: demand was strong enough that underwriters fully exercised the greenshoe, expanding the deal from a $75 billion base offering to $85.7 billion, meaning the stock never needed a defensive stabilization buyback at all. The fee implications of a fully exercised greenshoe are covered separately in our Underwriter Syndicate Economics guide.
Penalty Bids: The Other Tool Against Flipping
The greenshoe isn't the only mechanism underwriters have for keeping early trading orderly. A separate provision under the same Rule 104, called a penalty bid, lets the managing underwriter reclaim a broker's selling concession (the fee a broker earns for placing shares with investors) if that broker's clients "flip" their shares, meaning they sell within 30 days of the offering.
The logic is straightforward: if a broker's clients dump their allocation almost immediately, the syndicate arguably never got what it paid for, since the whole point of the selling concession was to reward brokers for finding investors who'd actually hold the stock. The SEC's own analysis notes that penalty bids are rarely assessed in practice, and tend to show up most often on weaker-demand deals, where the underwriter is trying hard to avoid a supply-driven price slide. FINRA Rule 5131 adds a guardrail on top of this: a firm can't selectively penalize individual brokers for their clients' flipping unless the penalty bid is applied across the entire syndicate, which stops the tool from being used to unfairly single out one broker's book of business.
A useful historical example of what stabilization looks like when it doesn't fully work: Blue Apron's 2017 IPO started trading, and by the end of day one, more investors wanted to sell than buy. That's exactly the scenario penalty bids and stabilizing bids exist to soften, and it's a reminder that these tools reduce volatility; they don't eliminate the underlying demand problem if a deal was priced too aggressively to begin with.
What Research Shows About Stabilization's Actual Effect on Trading
Stabilization isn't just a theoretical safety net. Ellul and Pagano's study of 337 London Stock Exchange IPOs, published in the Review of Financial Studies, found that bid-ask spreads (the gap between buying and selling price, a common measure of how easily a stock trades) and the broader Probability of Informed Trading measure both narrow steadily over the weeks following an IPO, consistent with underwriter support and improving liquidity working together to bring early volatility down. This is the same underlying dataset discussed in more depth in our pillar reference.
On the regulatory side,the SEC's own economic analysis found that in 2003, roughly 53% of equity IPOs involved a managing underwriter carrying out syndicate covering transactions (the open-market buybacks that happen when a stock trades below its offer price), averaging about 22 separate covering bids per IPO that used the mechanism. That's a useful benchmark: stabilization activity isn't a rare, exceptional event. It happens in roughly half of all IPOs to some degree.
One trade-off worth being aware of: stabilization keeps early trading orderly, but critics argue it can also delay a stock's true price discovery. If a company's actual market value sits below its offer price, greenshoe support can postpone that correction rather than prevent it, meaning the drop shows up later instead of disappearing entirely.
What to Watch For in the First 30 Days
For an institutional investor trying to tell real demand apart from underwriter support, a few concrete signals help.
- Check the S-1 for the overallotment size. It's almost always set at exactly 15% of the total offering, which tells you the maximum volume of shares underwriters can use to defend the price before that ammunition runs out. This is one of the specific disclosures covered in our S-1 Filing Analysis Framework.
- Watch for bid clustering right at the offer price. If a stock keeps returning to its exact IPO price and large buy orders keep absorbing sell pressure without the price actually moving, that's a reasonable sign of active stabilization rather than organic buying.
Checking a stock's level two order book during an active greenshoe window shows this pattern clearly: large buy orders tend to sit right at that exact offer price, absorbing sell pressure without the price budging, which is fairly easy to spot once you know exactly where to look.
- Pay attention to days 30 and 31. The stabilization window under Rule 104 typically closes 30 days after the IPO, the same 30-day window that defines "flipping" for penalty bid purposes. If underwriters have been actively defending the offer price, a sharp change in buy-side volume right around that date can signal the stock is now trading on its own, without that support.
Frequently Asked Questions
Does a fully exercised greenshoe mean a stock definitely won't need stabilization later?
Not necessarily. A fully exercised greenshoe, like SpaceX's, generally signals strong day-one demand, but stabilization needs can still arise later in the 30-day window if sentiment shifts or broader market conditions change. The two are related but not the same thing: one measures initial demand, the other is an ongoing defensive tool.
Is there a difference between a "stabilizing bid" and a "syndicate covering transaction"?
Yes. A stabilizing bid is a standing order placed at or below the offer price to support the market generally. A syndicate covering transaction specifically refers to underwriters buying shares on the open market to close out their short position from the initial oversale. Both fall under Rule 104, but they're technically distinct actions with separate disclosure requirements.
Do penalty bids affect individual retail investors who flip their shares, or just the brokers?
Just the brokers, at least directly. A penalty bid reclaims the selling concession from the broker whose client flipped the shares, not a fee charged to the investor themselves. That said, a broker facing repeated penalty bids has a real incentive to steer future allocations toward clients less likely to flip, which indirectly shapes who gets access to future hot IPOs.
Can an underwriter stabilize a stock on an exchange different from where it's listed?
Rule 104 permits stabilizing bids in the security's principal market, whether that's a US exchange or a foreign one, and allows the bid to be adjusted based on the prevailing price in that market, as long as it never exceeds the original offer price.
Do smaller or less-followed IPOs get the same stabilization treatment as major listings like SpaceX?
The legal mechanism is available to any underwritten IPO, but the SEC's own data shows syndicate covering transactions occur in roughly half of equity IPOs, meaning it's common but far from universal. Deal size, demand at pricing, and the underwriter's own risk appetite all influence whether stabilization actually gets used in practice.
Does the 30-day stabilization window align with any other post-IPO deadline investors should track?
No, and this is a common point of confusion. The greenshoe and stabilization window run 30 days from listing, while the lockup period, which restricts insiders from selling, typically runs 90 to 180 days. They're separate timelines managed by the same underwriting syndicate, and we cover the lockup side in detail in our Lockup Expiration Effects analysis.
